Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BGLCNASDAQ:MGRXNASDAQ:OTRKNYSE:SSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBGLCBioNexus Gene Lab$6.82-38.8%$3.22$2.01▼$15.60$20.01M5.08493,135 shs2.08 million shsMGRXMangoceuticals$1.52+0.7%$1.83$1.32▼$7.66$7.80M2.4219,078 shs158,891 shsOTRKOntrak$0.48+5.0%$1.42$0.42▼$5.53$1.94M2.16485,934 shs1.37 million shsSSYSunLink Health Systems$0.92+2.3%$0.91$0.62▼$1.91$6.50M1.11114,878 shs29,344 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBGLCBioNexus Gene Lab+262.87%+317.23%+156.09%+340.14%+137.02%MGRXMangoceuticals-0.66%-25.25%-27.75%-29.44%-97.95%OTRKOntrak-7.87%-56.21%-68.83%-68.72%-84.35%SSYSunLink Health Systems+2.56%-2.14%+3.26%-9.75%+14.71%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBGLCBioNexus Gene Lab0.6561 of 5 stars0.05.00.00.02.40.00.0MGRXMangoceuticals1.6711 of 5 stars0.05.00.00.02.71.70.6OTRKOntrak3.3044 of 5 stars3.55.00.00.02.70.01.3SSYSunLink Health SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBGLCBioNexus Gene Lab 0.00N/AN/AN/AMGRXMangoceuticals 0.00N/AN/AN/AOTRKOntrak 3.00Buy$45.009,216.77% UpsideSSYSunLink Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBGLCBioNexus Gene Lab$9.51M1.29N/AN/A$4.63 per share1.47MGRXMangoceuticals$620K12.67N/AN/A$4.30 per share0.35OTRKOntrak$10.85M0.19N/AN/A$2.34 per share0.21SSYSunLink Health Systems$31.09M0.21N/AN/A$2.00 per share0.46Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-22.85%-24.18%-20.14%N/AMGRXMangoceuticals-$8.71M-$4.640.00∞N/A-2,191.76%-72.81%-66.58%8/13/2025 (Estimated)OTRKOntrak-$25.49M-$15.81N/AN/AN/A-274.20%-269.88%-128.35%8/6/2025 (Estimated)SSYSunLink Health Systems-$1.53M$0.246.59∞N/A3.20%-20.94%-16.09%N/ALatest OTRK, MGRX, SSY, and BGLC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025OTRKOntrak-$1.24-$1.65-$0.41-$1.65N/A$2.02 million5/15/2025Q1 2025BGLCBioNexus Gene LabN/A-$0.03N/A-$0.03N/AN/A5/15/2025Q1 2025MGRXMangoceuticalsN/A-$1.29N/A-$1.29N/A$0.11 million4/14/2025Q4 2024OTRKOntrak-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBGLCBioNexus Gene LabN/AN/AN/AN/AN/AMGRXMangoceuticalsN/AN/AN/AN/AN/AOTRKOntrakN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBGLCBioNexus Gene LabN/A4.193.44MGRXMangoceuticalsN/A0.120.12OTRKOntrak0.540.720.72SSYSunLink Health SystemsN/A4.063.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBGLCBioNexus Gene Lab18.85%MGRXMangoceuticals56.72%OTRKOntrak12.95%SSYSunLink Health Systems23.67%Insider OwnershipCompanyInsider OwnershipBGLCBioNexus Gene Lab0.70%MGRXMangoceuticals16.00%OTRKOntrak1.90%SSYSunLink Health Systems27.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableMGRXMangoceuticals35.17 million4.34 millionNot OptionableOTRKOntrak2504.22 million4.14 millionNo DataSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableOTRK, MGRX, SSY, and BGLC HeadlinesRecent News About These CompaniesSunlink Health Systems Extends Merger Agreement DeadlineJune 23, 2025 | tipranks.comSunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter ResultsMay 13, 2025 | businesswire.comREGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTIONApril 15, 2025 | markets.businessinsider.comSunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter ResultsFebruary 12, 2025 | businesswire.comRegional Health Properties to merge with Sunlink Health SystemsJanuary 8, 2025 | mcknightsseniorliving.comMRegional Health, SunLink Health to merge in all-stock transactionJanuary 7, 2025 | markets.businessinsider.comSunLink Health Systems Inc (SSY) Stock Trading RecapJanuary 7, 2025 | bovnews.comBRegional Health Properties Shares More Than Double on SunLink Health DealJanuary 6, 2025 | marketwatch.comShareholder Alert: Ademi LLP Investigates Whether SunLink Health Systems, Inc. Is Obtaining a Fair Price for Its Public ShareholdersJanuary 6, 2025 | stockhouse.comSSY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SunLink Health Systems, Inc. Is Fair to ShareholdersJanuary 6, 2025 | tmcnet.comSunLink Health Systems Inc (SSY) Stock: Beyond the Surface of Its Performance?December 27, 2024 | bovnews.comBSunLink Health Systems IncNovember 18, 2024 | uk.investing.comSunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter ResultsNovember 13, 2024 | accesswdun.comAJPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into FridayOctober 12, 2024 | msn.comSunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real EstateOctober 10, 2024 | finance.yahoo.comSunLink Health Systems (AMEX:SSY) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comSunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual ResultsSeptember 30, 2024 | businesswire.comSunLink Health Systems, Inc. (SSY)August 1, 2024 | finance.yahoo.comSunLink Health Systems, Inc. Announces Sale of Trace Extended Care & RehabJune 3, 2024 | businesswire.comSSY Stock Earnings: SunLink Health Systems Reported Results for Q3 2024May 15, 2024 | investorplace.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOTRK, MGRX, SSY, and BGLC Company DescriptionsBioNexus Gene Lab NASDAQ:BGLC$6.82 -4.32 (-38.78%) Closing price 04:00 PM EasternExtended Trading$6.40 -0.42 (-6.09%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Mangoceuticals NASDAQ:MGRX$1.52 +0.01 (+0.66%) Closing price 04:00 PM EasternExtended Trading$1.52 0.00 (0.00%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.Ontrak NASDAQ:OTRK$0.48 +0.02 (+5.05%) Closing price 04:00 PM EasternExtended Trading$0.48 +0.00 (+0.41%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.SunLink Health Systems NYSE:SSY$0.92 +0.02 (+2.27%) Closing price 03:49 PM EasternExtended Trading$0.92 0.00 (0.00%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead Dan Ives’ Bold $5 Trillion Forecast for Microsoft Stock 3 Utility Stocks That Combine Income and Stability 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.